Universitätsklinikum Heidelberg

Molekulares Tumorboard bei urologischen Tumoren: Hoffnung oder Enttäuschung? (2025) Gaisa NT, Eckstein M, Casuscelli J, Kalogirou C, Zschäbitz S, Dörffer N, Reis H Journal article, Review article Mesoporous bioactive glass nanoparticles exhibit intrinsic angiogenic potential in the chorioallantoic membrane assay, without the addition of exogenous cells (2025) Moll MN, Nawaz Q, Kunisch E, Ahrens T, Walker T, Renkawitz T, Boccaccini AR, Westhauser F Journal article Letter to the editor. (2025) Wiltfang J, Hoffmann J, Schliephake H, Kesting MR, Al-Nawas B, Lethaus B Journal article, Letter Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell therapy (2025) Kaulen LD, Martinez-Lage M, Abramson JS, Karschnia P, Doubrovinskaia S, Shankar GM, Choi BD, et al. Journal article 40 Jahre Deutsche Gesellschaft für Geriatrie (DGG) – gefragt, gereift, gestärkt. Geschichte der DGG unter wissenschaftlichen und fachpolitischen Aspekten (2025) Hofmann W, Grund S, Wirth R, Bauer JM, Heppner HJ, Thiem U, Becher K, et al. Journal article, Review article Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis (2025) Ronnacker J, Muller PJ, Mikesch JH, Zukunft S, Weinbergerová B, Šrámek J, Valka J, et al. Journal article Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial. (2025) Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, et al. Journal article Guideline-recommended basic parameter adherence in neurocritical care stroke patients: Observational multicenter individual participant data analysis. (2025) Mrochen A, Alhaj Omar O, Pelz JO, Michalski D, Neugebauer H, Lehrieder D, Knier B, et al. Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article Long-term follow-up of real-world adjuvant anti-PD1 checkpoint inhibition and targeted therapy in stage III melanoma patients (2025) Lodde GC, Hassel JC, von Wasielewski I, Meier F, Mohr P, Kähler K, Hauschild A, et al. Journal article